Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
UBS
Federal Trade Commission
US Army
Harvard Business School
Daiichi Sankyo
Queensland Health
McKesson
Boehringer Ingelheim

Generated: April 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: deferasirox

« Back to Dashboard

deferasirox

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Novartis Pharms Corp JADENU SPRINKLE deferasirox GRANULE;ORAL 207968 NDA Novartis Pharmaceuticals Corporation N 0078-0713-15
Novartis Pharms Corp JADENU SPRINKLE deferasirox GRANULE;ORAL 207968 NDA Novartis Pharmaceuticals Corporation N 0078-0720-15
Novartis Pharms Corp JADENU SPRINKLE deferasirox GRANULE;ORAL 207968 NDA Novartis Pharmaceuticals Corporation N 0078-0727-15
Novartis EXJADE deferasirox TABLET, FOR SUSPENSION;ORAL 021882 NDA Novartis Pharmaceuticals Corporation N 0078-0468-15
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Daiichi Sankyo
Cipla
QuintilesIMS
Baxter
Harvard Business School
Merck
Dow